Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
FDA Approves Sanofi's Enzyme Therapy For Late-Onset Pompe Disease
Tickers SNY
Tags Biotech News General
From Benzinga
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
Tickers MRK REGN SNY XCUR
Tags Briefs REGN MRK
From Benzinga
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
Tickers REGN SNY
Tags News Biotech General
From Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Tickers ABSI ABUS ACAD ACXP
Tags RNA FDA CLBS
From Benzinga
How This Historic FDA Approval Benefits Viatris
Tickers ABBV RVNC SNY VTRS
Tags SNY VTRS RVNC
From Motley Fool
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Tickers ABSI ACET AERI AKRO
Tags Earnings BIO ALKS
From Benzinga
Why Translate Bio Stock Soared Today
Tickers SNY TBIO
Tags TBIO Market News SNY
From Motley Fool
Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge
Tickers ABVC ARCT BABA CPG
Tags Benzinga MOHO Mid/Afternoon Market Update
From Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Tickers ABSI ACET ADCT ADVM
Tags General AXNX NERV
From Benzinga
Sanofi Bets Big On mRNA Push With Translate Bio Acquisition For $3.2B: Highlights
Tickers SNY TBIO
Tags General TBIO Biotech
From Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
Tickers ALBO AXSM CARA CCXI
Tags ITRM SESN CCXI
From Benzinga
Sanofi (SNY) Q2 2021 Earnings Call Transcript
Tickers SNY
Tags Market News SNY
From Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Tickers ABBV ABOS ACET AGIO
Tags General FDA EVLO
From Benzinga
Sanofi Q2 Performance Benefits From Dupixent, Vaccines; Raises 2021 Profit Forecast
Tickers SNY
Tags Market News Health Care Earnings
From Benzinga
Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients
Tickers REGN SNY
Tags Skin Disorder Market News Health Care
From Benzinga
Earnings Scheduled For July 29, 2021
Tickers MPW MRC MRK MSTR
Tags TPX WAB YUM
From Benzinga
Sanofi's Pompe Disease Enzyme Replacement Therapy Gets EMA's CHMP Backing
Tickers CHMP SNY
Tags Briefs Health Care Pompe Disease
From Benzinga
7 Cheap Value Stocks to Buy for August 2021
Tickers AMZN BRK-A BRK-B CVS
Tags PG INCY HPQ
From InvestorPlace
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
Tickers ANY REGN SNY
Tags Market News Health Care COPD
From Benzinga
15 European Dividend Aristocrats to Diversify Your Portfolio
Tickers ASHTY BTI CLPBY DEO
Tags BTI DEO LRLCY
From InvestorPlace
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
Tickers CVAC GSK NVAX SNY
Tags GSK Briefs Health Care
From Benzinga
Sanofi's Oral Treatment For Sleeping Sickness Gets FDA Approval
Tickers SNY
Tags SNY FDA Briefs
From Benzinga
5 French Stocks To Consider For Bastille Day
Tickers BRRLY CRTO DANOY GSK
Tags BRRLY China Mengniu Dairy Company Ltd/ Earth Island
From Benzinga
Is This Coronavirus Stock Undervalued?
Tickers REGN SNY
Tags BAYR/Y SNY Market News
From Motley Fool
New Developments Have Made Vaxart Stock So Much More Attractive
Tickers SNY VXRT
Tags Market News Stocks to Buy VXRT
From InvestorPlace
Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India
Tickers GSK SNY
Tags Health Care Market News Government
From Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.